ANAGRELIDE MLabs anagrelide (as hydrochloride) 0.5 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

anagrelide mlabs anagrelide (as hydrochloride) 0.5 mg capsule blister pack

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: lactose; magnesium stearate; lactose monohydrate; povidone; crospovidone; microcrystalline cellulose; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagrelide mlabs capsules are indicated for the treatment of essential thrombocythaemia.

ANAGRELIDE MLabs anagrelide (as hysrochloride) 0.5 mg capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

anagrelide mlabs anagrelide (as hysrochloride) 0.5 mg capsule bottle

micro labs pty ltd - anagrelide hydrochloride, quantity: 0.57 mg (equivalent: anagrelide, qty 0.5 mg) - capsule, hard - excipient ingredients: lactose; povidone; lactose monohydrate; crospovidone; microcrystalline cellulose; magnesium stearate; titanium dioxide; gelatin; purified water; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - anagrelide mlabs capsules are indicated for the treatment of essential thrombocythaemia.

Xagrid European Union - English - EMA (European Medicines Agency)

xagrid

shire pharmaceutical contracts limited - anagrelide - thrombocythemia, essential - antineoplastic agents - xagrid is indicated for the reduction of elevated platelet counts in at-risk essential-thrombocythaemia (et) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.

Anagrelid Sandoz 0.5 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

anagrelid sandoz 0.5 mg hard caps.

sandoz sa-nv - anagrelide hydrochloride 0,61 mg - eq. anagrelide 0,5 mg - capsule, hard - 0,5 mg - anagrelide hydrochloride 0.61 mg - anagrelide

Atremia 0.5 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atremia 0.5 mg hard caps.

teva b.v. - anagrelide hydrochloride monohydrate 0,61 mg - eq. anagrelide 0,5 mg - capsule, hard - 0,5 mg - anagrelide hydrochloride monohydrate 0.61 mg - anagrelide

AGRYLIN CAPSULE Canada - English - Health Canada

agrylin capsule

takeda canada inc - anagrelide (anagrelide hydrochloride) - capsule - 0.5mg - anagrelide (anagrelide hydrochloride) 0.5mg - platelet-reducing agents

AGRYLIN CAPSULE 0.5 mg Singapore - English - HSA (Health Sciences Authority)

agrylin capsule 0.5 mg

takeda pharmaceuticals (asia pacific) pte. ltd. - anagrelide (as hcl) - capsule - 0.61mg - anagrelide (as hcl) 0.61mg

Xagrid 500microgram capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

xagrid 500microgram capsules

shire pharmaceuticals ltd - anagrelide hydrochloride - capsule - 500microgram

Anagrelide Zentiva 0,5 mg harde capsules Netherlands - English - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

anagrelide zentiva 0,5 mg harde capsules

Agrylin New Zealand - English - Medsafe (Medicines Safety Authority)

agrylin

takeda new zealand limited - anagrelide hydrochloride 0.61mg equivalent to 0.5 mg anagrelide - capsule - 0.5 mg - active: anagrelide hydrochloride 0.61mg equivalent to 0.5 mg anagrelide excipient: crospovidone gelatin lactose lactose monohydrate magnesium stearate microcrystalline cellulose povidone tekprint black sw-9008 titanium dioxide - agrylin capsules are indicated for the treatment of essential thrombocythaemia (et).